Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Injection for Diabetic Neuropathy
NCT03250403Completed
- Sponsor
- Assiut University
- Start
- Apr 2017
- Primary completion
- Aug 2017
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised, double-blind trial of platelet-rich plasma in diabetic peripheral neuropathy (DPN) (2 arms), sponsored by Assiut University. Primary endpoints: Numbness at 6 months and Pain at 6 months. Started Apr 2017; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT03250403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03250403.